1:46 PM
 | 
Jan 17, 2019
 |  BC Innovations  |  Finance

Public funding highlights

Public funding highlights

Selected developments and initiatives in 4Q18 from major sources of public funding including National Institutes of Health (NIH), the U.K.’s Medical Research Council (MRC), the Innovative Medicines Initiative (IMI), the Canadian Institutes of Health Research (CIHR), the Agency for Science Technology and Research (A*STAR) and the Japan Agency for Medical Research and Development (AMED).

DateAgencySummaryType
Oct. 1NIHThe INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down SyndromE) project awarded $22.2 million in grants as part of NIH's $59 million mandate for Down syndrome research in FY18.Grants
Oct. 1CIHRMichael Strong began his tenure as CIHR president, replacing Acting President Roderick McInnes. Strong named Tammy Clifford as VP of research programs on Oct. 4, and Rick Glazier as scientific director of the CIHR Institute of Health Services and Policy Research on Oct. 9.Personnel
Oct. 1IMI; European Medicines Agency (EMA); U.S. Food and Drug Administration (FDA)IMI published a report on its 2017 IMI-EMA-FDA Regulatory Science Summit, underscoring the need to collaborate within and between sectors, break down cultural barriers and support...

Read the full 978 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$100 USD
More Info >